Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed May 2, 2013
Insider Transaction Report
Form 4
KEHL JOHN H JR
CVP, Strategy & Corp Dev
Transactions
- Exercise/Conversion
Common Stock
2013-05-01$21.95/sh+12,500$274,438→ 115,339.004 total - Sale
Common Stock
2013-05-01$63.54/sh−300$19,062→ 115,039.004 total - Sale
Common Stock
2013-05-01$62.70/sh−12,200$764,940→ 102,839.004 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-05-01−12,500→ 0 totalExercise: $21.95From: 2007-05-11Exp: 2013-05-10→ Common Stock (12,500 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $63.39 to $63.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $62.39 to $63.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.